Literature DB >> 17255131

Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes.

Angelique L Rops1, Cor W Jacobs, Peter C Linssen, Jan B Boezeman, Joost F Lensen, Tessa J Wijnhoven, Lambert P van den Heuvel, Toin H van Kuppevelt, Johan van der Vlag, Jo H Berden.   

Abstract

BACKGROUND: Proliferative glomerulonephritides are characterized by the influx of leucocytes. Heparan sulfate (HS) plays an important role in the recruitment, rolling and firm adhesion of leucocytes to activated endothelium. Recently, we have shown the importance of HS on activated mouse glomerular endothelial cells (mGEnC-1) for the firm adhesion of leucocytes in a static adhesion assay. In the present study, we evaluated the role of HS on glomerular endothelial cells and the effect of adding heparinoids on the leucocyte-glomerular endothelium interaction under dynamic flow conditions.
METHODS: The number of rolling and firmly adhering leucocytes, and the rolling velocity of leucocytes was determined on a monolayer of unactivated or TNF-alpha-activated mGEnC-1 under dynamic flow conditions using physiological relevant shear stress rates in a flow chamber system. Furthermore, the effects of removal of HS on TNF-alpha-activated mGEnC-1 by heparinase III treatment, and of different concentrations of heparin, tinzaparin and HS, on the rolling and adhesion of leucocytes were evaluated.
RESULTS: At the calculated physiological shear stress rate of 0.8 dynes/cm2 the number of rolling and firmly adhering leucocytes to mGEnC-1 increased 2-fold after activation with TNF-alpha, whereas the rolling velocity of the leucocytes decreased 2-fold. Addition of heparin, tinzaparin or HS, and the removal of HS on mGEnC-1 reduced the number of leucocytes rolling and adhering to activated mGEnC-1 about 2-3-fold, while the rolling velocity increased more than 2-fold.
CONCLUSIONS: HS on activated glomerular endothelial cells is important for the interaction with leucocytes under flow conditions, while exogenous heparinoids interfere with this interaction. These results suggest that supplementary treatment of proliferative glomerulonephritides with heparinoids is an interesting option to pursue.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17255131     DOI: 10.1093/ndt/gfl801

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  16 in total

1.  Dynamic regulation of ROCK in tumor cells controls CXCR4-driven adhesion events.

Authors:  Amanda P Struckhoff; Jason R Vitko; Manish K Rana; Carter T Davis; Kamau E Foderingham; Chi-Hsin Liu; Lyndsay Vanhoy-Rhodes; Steven Elliot; Yun Zhu; Matt Burow; Rebecca A Worthylake
Journal:  J Cell Sci       Date:  2010-01-05       Impact factor: 5.285

Review 2.  Role of the endothelial surface layer in neutrophil recruitment.

Authors:  Alex Marki; Jeffrey D Esko; Axel R Pries; Klaus Ley
Journal:  J Leukoc Biol       Date:  2015-05-15       Impact factor: 4.962

3.  Protein-bound uremic toxins stimulate crosstalk between leukocytes and vessel wall.

Authors:  Anneleen Pletinck; Griet Glorieux; Eva Schepers; Gerald Cohen; Bertrand Gondouin; Maria Van Landschoot; Sunny Eloot; Angelique Rops; Johan Van de Voorde; An De Vriese; Johan van der Vlag; Philippe Brunet; Wim Van Biesen; Raymond Vanholder
Journal:  J Am Soc Nephrol       Date:  2013-09-05       Impact factor: 10.121

Review 4.  New approaches to the treatment of dense deposit disease.

Authors:  Richard J H Smith; Jessy Alexander; Paul N Barlow; Marina Botto; Thomas L Cassavant; H Terence Cook; Santiago Rodriguez de Córdoba; Gregory S Hageman; T Sakari Jokiranta; William J Kimberling; John D Lambris; Lynne D Lanning; Vicki Levidiotis; Christoph Licht; Hans U Lutz; Seppo Meri; Matthew C Pickering; Richard J Quigg; Angelique L Rops; David J Salant; Sanjeev Sethi; Joshua M Thurman; Hope F Tully; Sean P Tully; Johan van der Vlag; Patrick D Walker; Reinhard Würzner; Peter F Zipfel
Journal:  J Am Soc Nephrol       Date:  2007-08-05       Impact factor: 10.121

5.  Preclinical and clinical evidence of nephro- and cardiovascular protective effects of glycosaminoglycans.

Authors:  Arrigo F Cicero; Sibel Ertek
Journal:  Arch Med Sci       Date:  2010-09-07       Impact factor: 3.318

6.  RNA Contaminates Glycosaminoglycans Extracted from Cells and Tissues.

Authors:  Jasper J van Gemst; Markus A Loeven; Mark J J de Graaf; Jo H M Berden; Ton J Rabelink; Cornelis H Smit; Johan van der Vlag
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

7.  Adhesion of Escherichia coli under flow conditions reveals potential novel effects of FimH mutations.

Authors:  T Feenstra; M S Thøgersen; E Wieser; A Peschel; M J Ball; R Brandes; S C Satchell; T Stockner; F M Aarestrup; A J Rees; R Kain
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-05       Impact factor: 3.267

8.  Quercetin nanoparticle complex attenuated diabetic nephropathy via regulating the expression level of ICAM-1 on endothelium.

Authors:  Fei Tong; Suhuan Liu; Bing Yan; Xuejun Li; Shiwei Ruan; Shuyu Yang
Journal:  Int J Nanomedicine       Date:  2017-10-24

9.  A role for the endothelial glycosaminoglycan hyaluronan in neutrophil recruitment by endothelial cells cultured for prolonged periods.

Authors:  Lynn M Butler; G Ed Rainger; Gerard B Nash
Journal:  Exp Cell Res       Date:  2009-08-28       Impact factor: 3.905

10.  The effect of shiga toxin on weibel-palade bodies in primary human endothelial cells.

Authors:  Joyce Geelen; Maartje van den Biggelaar; Peter Linssen; Thea van der Velden; Koen Mertens; Leo Monnens
Journal:  Nephron Extra       Date:  2014-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.